StockData

China Pharma Holdings, Inc. (CPHI) stock

CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.50+0.02 (+4.17%)

Close on Nov 17, 2026Market cap $21.51MP/E –Yield –

China Pharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

China Pharma's pe ratio was 41.5× on Jul 31, 2013, against 9.4× a year earlier. Over the last 3 years it ranged from 8.8× to 51.3×, with a median of 18.6×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2013Jul 31, 201341.5×+32.6
2012Dec 31, 20128.9×−5.7
2011Dec 30, 201114.6×–

More China Pharma figures

See a number that looks wrong?